FI63577C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3,4-dihydropyrimido(1,2-a)bentsimidatsol-2(1h)-on-derivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3,4-dihydropyrimido(1,2-a)bentsimidatsol-2(1h)-on-derivat Download PDF

Info

Publication number
FI63577C
FI63577C FI773724A FI773724A FI63577C FI 63577 C FI63577 C FI 63577C FI 773724 A FI773724 A FI 773724A FI 773724 A FI773724 A FI 773724A FI 63577 C FI63577 C FI 63577C
Authority
FI
Finland
Prior art keywords
formula
mixture
dihydropyrimido
benzimidazol
compound
Prior art date
Application number
FI773724A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI773724A (fi
FI63577B (fi
Inventor
Stuart Dennett Mills
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of FI773724A publication Critical patent/FI773724A/fi
Application granted granted Critical
Publication of FI63577B publication Critical patent/FI63577B/fi
Publication of FI63577C publication Critical patent/FI63577C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI773724A 1976-12-09 1977-12-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3,4-dihydropyrimido(1,2-a)bentsimidatsol-2(1h)-on-derivat FI63577C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB5142676 1976-12-09
GB3334177 1977-08-09
GB3334177 1977-08-09

Publications (3)

Publication Number Publication Date
FI773724A FI773724A (fi) 1978-06-10
FI63577B FI63577B (fi) 1983-03-31
FI63577C true FI63577C (fi) 1983-07-11

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773724A FI63577C (fi) 1976-12-09 1977-12-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3,4-dihydropyrimido(1,2-a)bentsimidatsol-2(1h)-on-derivat

Country Status (23)

Country Link
US (1) US4167569A (de)
JP (1) JPS5390296A (de)
AT (1) AT359068B (de)
AU (1) AU514427B2 (de)
CA (1) CA1086727A (de)
CH (1) CH633291A5 (de)
CS (1) CS199696B2 (de)
DD (1) DD133330A5 (de)
DE (1) DE2754930A1 (de)
ES (1) ES464862A1 (de)
FI (1) FI63577C (de)
FR (1) FR2373543A1 (de)
GR (1) GR65298B (de)
HU (1) HU176540B (de)
IE (1) IE45924B1 (de)
IL (1) IL53507A (de)
IT (1) IT1143729B (de)
NL (1) NL7713658A (de)
NO (1) NO774216L (de)
NZ (1) NZ185823A (de)
PL (1) PL107142B1 (de)
SE (1) SE435385B (de)
SU (1) SU843751A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
BR112014032581A8 (pt) 2012-06-27 2018-08-14 4Sc Discovery Gmbh inibidores de bifluorodioxalano-amino-benzimidazol quinase para o tratamento de câncer, distúrbios do snc e inflamação autoimune

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Also Published As

Publication number Publication date
SE7713958L (sv) 1978-06-10
JPS5390296A (en) 1978-08-08
NZ185823A (en) 1980-08-26
FR2373543A1 (fr) 1978-07-07
US4167569A (en) 1979-09-11
PL107142B1 (pl) 1980-01-31
IE45924B1 (en) 1982-12-29
FI773724A (fi) 1978-06-10
DD133330A5 (de) 1978-12-27
HU176540B (en) 1981-03-28
IT1143729B (it) 1986-10-22
AU3112177A (en) 1979-06-07
PL202753A1 (pl) 1978-10-09
CH633291A5 (de) 1982-11-30
AU514427B2 (en) 1981-02-12
FI63577B (fi) 1983-03-31
IL53507A (en) 1981-07-31
AT359068B (de) 1980-10-27
CS199696B2 (en) 1980-07-31
DE2754930A1 (de) 1978-06-15
ATA883677A (de) 1980-03-15
CA1086727A (en) 1980-09-30
IL53507A0 (en) 1978-03-10
NL7713658A (nl) 1978-06-13
GR65298B (en) 1980-08-01
NO774216L (no) 1978-06-12
FR2373543B1 (de) 1980-05-16
SE435385B (sv) 1984-09-24
IE45924L (en) 1978-06-09
ES464862A1 (es) 1979-01-01
SU843751A3 (ru) 1981-06-30

Similar Documents

Publication Publication Date Title
US6610684B2 (en) Fused azepinone cyclin dependent kinase inhibitors
PT760819E (pt) Derivado dicarbonilicos triciclicos
HU218950B (hu) Kondenzált imidazo-piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CS277446B6 (en) Novel heteroazepines, process of their preparation and pharmaceutical preparations containing thereof
WO1996028429A1 (en) 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
CA2344828A1 (en) ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives
DK164704B (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
SK33995A3 (en) Imidazodiazepines
NL8701071A (nl) Chinolinecarboxylzuurderivaten.
JPH0725762B2 (ja) 三環式化合物
Peter Adenine isosteres with bridgehead nitrogen. Part 1. Two independent syntheses of the [1, 2, 4] triazolo [1, 5-a][1, 3, 5] triazine ring system leading to a range of substituents in the 2, 5 and 7 positions
NZ247643A (en) Benzimidazole compounds, preparation and pharmaceutical compositions thereof
FI63577C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3,4-dihydropyrimido(1,2-a)bentsimidatsol-2(1h)-on-derivat
NO873108L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
CA3176493A1 (en) Cbp/ep300 inhibitor and use thereof
Titova et al. 4-(Het) aryl-4, 7-dihydroazolopyrimidines and Their Tuberculostatic Activity
US4495187A (en) Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
CS203184B2 (en) Process for preparing new pyrroloquinoxalinones and pyrrolobenzodiazepinones
EP0107455B1 (de) Triazoloquinoxaline als Antidepressions- und Antiermüdungsmittel
US4547501A (en) Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
CA3135449A1 (en) Triazolopyrimidines based on thymine nucleobase and methods for producing them
US5173492A (en) s-Triazolo(3,4-I)purine derivatives
FI74011C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara /1,2,4/triazolo/4,3-a/kinoxalin-4-aminderivat.
Gueiffier et al. Heterocyclic compounds with a bridgehead nitrogen atom. Synthesis in the imidazo [1, 2‐c] quinazoline series
NZ244983A (en) Process for the preparation of process for the preparation of 5,7-diaryloxy-2-(heteroaryl)-1,2,4-triazolo[1,5-a][1,3,5]triazines

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES LIMITED